全文获取类型
收费全文 | 5518篇 |
免费 | 367篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 200篇 |
妇产科学 | 61篇 |
基础医学 | 544篇 |
口腔科学 | 97篇 |
临床医学 | 439篇 |
内科学 | 1078篇 |
皮肤病学 | 151篇 |
神经病学 | 338篇 |
特种医学 | 214篇 |
外国民族医学 | 1篇 |
外科学 | 973篇 |
综合类 | 136篇 |
一般理论 | 6篇 |
预防医学 | 321篇 |
眼科学 | 147篇 |
药学 | 664篇 |
中国医学 | 40篇 |
肿瘤学 | 406篇 |
出版年
2023年 | 48篇 |
2022年 | 163篇 |
2021年 | 224篇 |
2020年 | 119篇 |
2019年 | 156篇 |
2018年 | 185篇 |
2017年 | 114篇 |
2016年 | 153篇 |
2015年 | 154篇 |
2014年 | 213篇 |
2013年 | 269篇 |
2012年 | 394篇 |
2011年 | 376篇 |
2010年 | 218篇 |
2009年 | 192篇 |
2008年 | 310篇 |
2007年 | 303篇 |
2006年 | 298篇 |
2005年 | 261篇 |
2004年 | 221篇 |
2003年 | 212篇 |
2002年 | 167篇 |
2001年 | 130篇 |
2000年 | 114篇 |
1999年 | 103篇 |
1998年 | 36篇 |
1997年 | 32篇 |
1996年 | 32篇 |
1995年 | 34篇 |
1994年 | 28篇 |
1993年 | 31篇 |
1992年 | 70篇 |
1991年 | 66篇 |
1990年 | 48篇 |
1989年 | 43篇 |
1988年 | 47篇 |
1987年 | 34篇 |
1986年 | 32篇 |
1985年 | 46篇 |
1984年 | 38篇 |
1983年 | 22篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1979年 | 21篇 |
1978年 | 10篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1972年 | 10篇 |
1971年 | 12篇 |
1968年 | 9篇 |
排序方式: 共有5904条查询结果,搜索用时 15 毫秒
71.
Shah Umang V. Olusanmi Dolapo Narang Ajit S. Hussain Munir A. Tobyn Michael J. Hinder Steve J. Heng Jerry Y. Y. 《Pharmaceutical research》2015,32(1):248-259
Pharmaceutical Research - Surface area and surface energy of pharmaceutical powders are affected by milling and may influence formulation, performance and handling. This study aims to decouple the... 相似文献
72.
Nathan J Kolla Brittany Matthews Alan A Wilson Sylvain Houle R Michael Bagby Paul Links Alexander I Simpson Amina Hussain Jeffrey H Meyer 《Neuropsychopharmacology》2015,40(11):2596-2603
Antisocial personality disorder (ASPD) often presents with highly impulsive, violent behavior, and pathological changes in the orbitofrontal cortex (OFC) and ventral striatum (VS) are implicated. Several compelling reasons support a relationship between low monoamine oxidase-A (MAO-A), an enzyme that regulates neurotransmitters, and ASPD. These include MAO-A knockout models in rodents evidencing impulsive aggression and positron emission tomography (PET) studies of healthy subjects reporting associations between low brain MAO-A levels and greater impulsivity or aggression. However, a fundamental gap in the literature is that it is unknown whether brain MAO-A levels are low in more severe, clinical disorders of impulsivity, such as ASPD. To address this issue, we applied [11C] harmine PET to measure MAO-A total distribution volume (MAO-A VT), an index of MAO-A density, in 18 male ASPD participants and 18 age- and sex-matched controls. OFC and VS MAO-A VT were lower in ASPD compared with controls (multivariate analysis of variance (MANOVA): F2,33=6.8, P=0.003; OFC and VS MAO-A VT each lower by 19%). Similar effects were observed in other brain regions: prefrontal cortex, anterior cingulate cortex, dorsal putamen, thalamus, hippocampus, and midbrain (MANOVA: F7,28=2.7, P=0.029). In ASPD, VS MAO-A VT was consistently negatively correlated with self-report and behavioral measures of impulsivity (r=−0.50 to −0.52, all P-values<0.05). This study is the first to demonstrate lower brain MAO-A levels in ASPD. Our results support an important extension of preclinical models of impulsive aggression into a human disorder marked by pathological aggression and impulsivity. 相似文献
73.
Mikhail-Paul Cardinal Samuel Blais Anne Dumas Vincent Hamilton Eric Larose Stéphanie LeBlanc Julie Déry Heynric Grotenhuis Tim Leiner Wadi Mawad Cassandre Têtu Steven C. Greenway Nicole Dahl David Patton Arif Hussain Christian Drolet Gérald Gahide Paul Farand Frederic Dallaire 《The Canadian journal of cardiology》2021,37(3):417-424
BackgroundReference values for cardiac magnetic resonance imaging (cMRI) in children and young adults are scarce. This leads to risk stratification of patients with congenital heart diseases being based on volumes indexed to body surface area (BSA). We aimed to produce cMRI Z score equations for ventricular volumes in children and young adults and to test whether indexing to BSA resulted in an incorrect assessment of ventricular dilation according to sex, body composition, and growth.MethodsWe retrospectively included 372 subjects aged < 26 years with either normal hearts or conditions with no impact on ventricular volumes (reference group), and 205 subjects with repaired tetralogy of Fallot (TOF) aged < 26 years. We generated Z score equations by means of multivariable regression modelling. Right ventricular dilation was assessed with the use of Z scores and compared with indexing to BSA in TOF subjects.ResultsVentricular volume Z scores were independent from age, sex, and anthropometric measurements, although volumes indexed to BSA showed significant residual association with sex and body size. In TOF subjects, indexing overestimated dilation in growing children and underestimated dilation in female compared with male subjects, and in overweight compared with lean subjects.ConclusionsIndexed ventricular volumes measured with cMRI did not completely adjust for body size and resulted in a differential error in the assessment of ventricular dilation according to sex and body size. Our proposed Z score equations solved this problem. Future studies should evaluate if ventricular volumes expressed as Z scores have a better prognostic value than volumes indexed to BSA. 相似文献
74.
Human vascular endothelial cells with extended life spans: in vitro cell response,protein expression,and angiogenesis 总被引:4,自引:0,他引:4
Gagnon E Cattaruzzi P Griffith M Muzakare L LeFlao K Faure R Béliveau R Hussain SN Koutsilieris M Doillon CJ 《Angiogenesis》2002,5(1-2):21-33
An in vitro angiogenesis system was designed for screening angiogenic agonists and antagonists. In order to obtain large quantities of cells and reproducibility, human endothelial cells with extended life spans were developed by retroviral transfection. The resulting cells grown in a serum-free medium containing endothelial cell growth supplement (ECGS) have a telomerase activity, extended life spans of at least 21 passages, and an endothelial cell phenotype (diI-acetylated-LDL upake, factor VIII-related antigen, VEGFR-1 and R-2, and tissue-type plasminogen activator (tPA)) that resembled that of unaltered primary endothelial cells. Exceptions were (i) a higher expression of tPA, and (ii) a non-significant growth response to FGF-2 or VEGF stimulation. Within three-dimensional fibrin gels, specific cell clones rapidly formed tubular structures in a more reproducible manner than those observed with low-passage primary cells. Tube formation by primary endothelial cells and those with extended life spans was dependent upon FGF-2 and ECGS, respectively. Both cell types produced FGF-2 and VEGF cytokines. Increasing doses of suramin significantly decreased the size of microvessels formed by both cell lines. These functional results indicate that a vascular matrix system containing human cells with extended life spans can be successfully utilized as an in vitro assay for antiangiogenic compounds. 相似文献
75.
76.
K. J. Skeith MD M. S. Hussain R. T. Coutts C. Ramos-Remus J. A. Avina-Zubieta A. S. Russell 《Clinical rheumatology》1997,16(3):291-295
Summary
Objective: To assess the frequency of adverse drug reaction in patients with fibromyalgia in relation to medications prescribed for this condition. To evaluate the potential role of the P450IID6 phenotype in the pathogenesis of these adverse drug reactions.
Methods: Thirty-five patients with fibromyalgia were assessed using a structured questionnaire with demographic and clinical data and perceived adverse drug reactions. A sample of 60 patients with rheumatoid arthritis and 62 patients with localized back pain served as controls. The P450IID6 phenotype was determined for each of the fibromyalgia patients.
Results: Overall, 141 patients had used NSAID and 79 (56%) of them reported adverse effects. Antidepressant drugs were used by 68 patients and 35 (51%) patients had adverse effects. Muscle relaxant drugs were used by 48 patients and 15 (31%) of them reported side effects. Analgesics were used by 122 patients and 22 (18%) had experienced adverse effects. Statistical differences in the frequency of adverse effects were found with antidepressant drugs in the fibromyalgia group, compared with rheumatoid arthritis (p=0.01) and back pain (p=0.02). Four of the 35 patients (11.4%) had a metabolic ratio (M.R.) greater than 0.30 (log M.R.=–0.52) indicative of the poor metabolizers (PM) phenotype. M.R. varied from 0.005 (log M.R.=–2.30) to 4.99 (log M.R.=0.70).
Conclusions: The problem of adverse drug reactions in fibromyalgia patients does not appear to correlate with the PM phenotype of the P450IID6 oxidative enzyme. It also is unlikely that altered xenobiotic detoxification attributable to this PM phenotype would have a significant role in the development of fibromyalgia. 相似文献
77.
78.
R. Hussain 《Annals of human biology》2013,40(2):145-153
Knowledge of historical demography and contemporary social stratification can be valuable in understanding disease patterns, including genetic disorders, especially in communities that have a high prevalence of endogamous and/or consanguineous marriages. This paper provides a background to the religious, historical and socio-cultural factors that have helped define the bounds of endogamy for Muslims in undivided India and more specifically since the creation of Pakistan. The preference for endogamous marriage is based on the clan-oriented nature of the society, which values and actively seeks similarities in social group identity based on several factors, including religious, sectarian, ethnic, and tribal/clan affiliation. Religious affiliation is itself multi-layered and includes religious considerations other than being Muslim, such as sectarian identity (e.g. Shia or Sunni, etc.) and religious orientation within the sect (Isnashari, Ismaili, Ahmedi, etc.). Both ethnic affiliation (e.g. Sindhi, Baloch, Punjabi, etc.) and membership of specific biraderis or zat/quoms are additional integral components of social identity. Within the bounds of endogamy defined by the above parameters, close consanguineous unions are preferential due to a congruence of key features of group- and individual-level background factors. 相似文献
79.
Ramnath Santosh Ramanathan Dolora Wisco Daniel Vela-Duarte Atif Zafar Ather Taqui Stacey Winners A Blake Buletko Fredrick Hustey Andrew Reimer Andrew Russman Ken Uchino M Shazam Hussain 《Journal of stroke and cerebrovascular diseases》2021,30(7):105801
ObjectivesMobile stroke unit (MSU) has been shown to rapidly provide pre-hospital thrombolysis in acute ischemic stroke (AIS). MSU encounters neurological disorders other than AIS that require emergent treatment.Methods/MaterialsWe obtained pre-hospital diagnosis and treatment data from the prospectively collected dataset on 221 consecutive MSU encounters. Based on initial clinical evaluation and neuroimaging obtained on MSU, the diagnosis of AIS (definite, probable, and possible AIS, transient ischemic attack), intracranial hemorrhage, and likely stroke mimics was made.ResultsFrom July 2014 to April 2015, 221 patients were treated on MSU. 78 (35%) patients had initial clinical diagnosis of definite/probable AIS or TIA, 69 (31%) were diagnosed as possible AIS or TIA, 15 (7%) had intracranial hemorrhage while 59 patients (27%) were diagnosed as likely stroke mimics. Stroke mimics encountered included 13 (6%) metabolic encephalopathy, 11 (5%) seizures, 9 (4%) migraines, 3 (1%) substance abuse, 2 (1%) CNS tumor, 3 (1%) infectious etiology and 3 (1%) hypoglycemia. Fifty-four (24%) patients received non-thrombolytic treatments on MSUConclusionAbout one third of MSU encounters were not AIS initially, including intracranial hemorrhage and stroke mimics. MSU can be utilized to provide pre-hospital treatments in emergent neurological conditions other than AIS. 相似文献
80.
Mostafa Jafari Thanh N. Nguyen Santiago Ortega-Gutierrez Muhammad Shazam Hussain Ameer E. Hassan Asad Ikram Javed Khader Eliyas Gustavo J. Rodriguez Afshin A. Divani 《Journal of stroke and cerebrovascular diseases》2021,30(3):105556
Objectives/BackgroundMedical therapy is the first line of treatment for intracranial atherosclerotic disease (ICAD). Percutaneous transluminal angioplasty and stenting (PTAS) are mainly considered for those patients with severe stenosis and recurrent events despite aggressive medical therapy. In this review, we discuss the application of PTAS as a treatment option for ICAD and its future prospect.Materials and MethodsWe did the literature review of the key articles and guidelines to elaborate on the role of PTAS in the management of ICAD based on the current data and expert opinion. We searched PubMed, Google Scholar, and Scopus up to August 2020, and included articles published only in the English language.ResultsSince the publication of the results from SAMMPRIS and VISSIT trials, stenting is no longer recommended for secondary stroke prevention in patients with symptomatic ICAD. However, recent clinical studies on intracranial stenting for a subgroup of ICAD patients have shown promising results, likely due to better patient selection and continued advancement of endovascular techniques.ConclusionThere exists a lack of consensus regarding the best endovascular treatment approach (e.g., angioplasty alone or balloon mounted stent vs. self-expanding stent with or without prior angioplasty) or management of in-stent restenosis. Another area of clinical controversy relates to the ideal use and duration of antiplatelet therapy. 相似文献